Biomarin Pharmaceutical Inc
BMRN
$54.13-0.01 (-0.02%)
Jun 26, 2025, 12:43 PM
Financials
| 52Week High | 94.85 | 52Week Low | 52.93 |
| Beta | 0.18 | Current Ratio Annual | 5.33 |
| Current Ratio Quarterly | 5.52 | Gross Margin TTM | 79.44 |
| Market Cap | 10.37B | Net Profit Margin TTM | 17.76 |
| Operating Margin TTM | 21.00 | Price To Book | 1.79 |
| Price To Earnings TTM | 19.79 | Price To Free Cash Flow TTM | 16.72 |
| Price To Sales TTM | 3.51 | Quick Ratio Annual | 3.29 |
| Quick Ratio Quarterly | 3.49 | Return On Assets TTM | 7.47 |
| Return On Equity TTM | 9.46 | Return On Investment TTM | 8.37 |
| Revenue Growth3Y | 15.62 | Revenue Growth5Y | 10.86 |
| Revenue Growth Quarterly Yoy | 14.84 | Revenue Growth TTMYoy | 19.36 |
| Revenue Per Share TTM | 15.02 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 542 | 2 | 1 | 10 | 6 | 3 | 186.85M | $11.98B |
| Mar 31, 2025 | 570 | 89 | 60 | 232 | 176 | 61 | 184.22M | $12.66B |
| Change | 28(5%) | 87(4350%) | 59(5900%) | 222(2220%) | 170(2833%) | 58(1933%) | 2.63M(1%) | $678.71M(6%) |